Search

Search Constraints

You searched for: Author/Creator Kiang, Anna-Sophia

Search Results

1. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

2. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

3. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

4. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

5. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

6. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

7. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

8. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

9. Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy. Issue 1 (5th May 2020)

10. Therapeutic potential of AAV-mediated MMP-3 secretion from corneal endothelium in treating glaucoma. (1st February 2017)